Upcoming Webinar: How to Understand and Leverage Your Data

White Paper

KMK Value Based Medicine

Sales Force Effectiveness

Share on facebook
Share on twitter
Share on linkedin

Delivering Customer Value
Accelerating Brand Performance in an Era of Value-based Medicine

Delivering exception customer value – we hear about it every day within the circles of sales and marketing, but what does it really mean? Why is it important, and in the end, does it really matter? Clearly, questioning if value matters is a bit “tongue in cheek”. Intuitively, we can probably all agree that delivering value to our customers is certainly the right thing to do. It builds customer loyalty, deepens customer relationships, and ultimately, builds brand equity.

Download White Paper

For Questions, Contact Us Now

Related insights

Migraine Study Demonstrates Impact of Treatment Failures on Healthcare System

KMK Welcomes Oncology Market Research Veteran Lisa Logan

The Ultimate Plan for Strong Analytics Support to Drive Business Decisions : A no-compromise solution on quality and value

A Roadmap to Success: Five Guiding Principles to Incentive Compensation Planning

Pharma Companies’ Sales Reporting Efforts Often Fall Short. A look at why this occurs and how to avoid it in the future.

Unlock forward looking Insights via Machine Learning

KMK President Michael Karbachinskiy Weighs in on the use of AI and Machine Learning in Pharmaceutical Sales

GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

Readjusting Your Field Force in the World of COVID-19

How to Reach Oncologists when Face-to-Face Interaction is Impossible

KMK’s Split Credit Tool Improves IC Performance

KMK’s Employee Performance Tool Streamlines HQ/Sales Rep Calibration

Field Force Re-Optimization in Anticipation of Loss of Exclusivity (LOE)

IC Plan Design in Defense of Competitive Entry

Sales Force Effectiveness for Top 20 Pharma